|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Loans held for investment at fair value (cost of $53,744,253 and $50,241,018 at December 31, 2025 and 2024, respectively, net) | ||||||||||||||||||||
| Loans held for investment at carrying value, net | ||||||||||||||||||||
| Loan receivable held at carrying value, net | ||||||||||||||||||||
| Current expected credit loss reserve | ||||||||||||||||||||
| Loans held for investment at carrying value and loan receivable held at carrying value, net of current expected credit loss reserve | ||||||||||||||||||||
| Non-controlled, non-affiliated investments at fair value (cost of $354,320,536) | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Due from affiliate | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Interest reserve | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Due to affiliate | ||||||||||||||||||||
| Current expected credit loss reserve | ||||||||||||||||||||
| Distribution payable | ||||||||||||||||||||
| Management fee payable | ||||||||||||||||||||
| Income based incentive fee payable | ||||||||||||||||||||
| Accrued direct administrative expenses | ||||||||||||||||||||
| Director fees payable | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Amounts payable for common stock repurchased | ||||||||||||||||||||
| Senior notes payable, net | ||||||||||||||||||||
| Line of credit payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total line of credit payable | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Net assets | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share, 10,000 shares authorized at December 31, 2025 and 2024 and 0 shares issued and outstanding at December 31, 2025 and 2024, respectively | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 50,000,000 shares authorized; 22,689,438 shares issued and outstanding at June 30, 2026 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributable (loss) earnings | ||||||||||||||||||||
| Total net assets | ||||||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Net asset value per share (in dollars per share) | ||||||||||||||||||||
Loading...
